DT
HealthMore in Health→
Experimental Parkinson’s drug posts early signal by lowering linked protein in first human trial
Key Takeaways
- First-in-human trial reported encouraging effects.
- Experimental drug is designed to silence a gene strongly linked to Parkinson’s disease.
- Study said the therapy cut a Parkinson’s-linked protein by up to 60%.
- Findings were reported in Nature Medicine.
DE
DT Editorial Team··via medicalxpress.com